Increased HMGCS2 expression in diabetes enhanced the production of ketone bodies, thus leading to diabetic cardiomyopathy (Wang et al, 2020a), whereas the function of HMGCS2 in diabetic nephropathy remains controversial. Here, HMGCS2 is linked to diabetic cardiomyopathy.